LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
6.92
+0.06 (0.87%)
At close: Sep 11, 2026, 4:00 PM EDT
6.99
+0.07 (1.01%)
After-hours: Sep 11, 2026, 7:30 PM EDT
LeonaBio Employees
LeonaBio had 19 employees as of December 31, 2025. The number of employees decreased by 7 or -26.92% compared to the previous year.
Employees
19
Change (1Y)
-7
Growth (1Y)
-26.92%
Revenue / Employee
n/a
Profits / Employee
-$7,445,000
Market Cap
65.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | -7 | -26.92% | 19 | 0 |
| Dec 31, 2024 | 26 | -41 | -61.19% | 26 | 0 |
| Dec 31, 2023 | 67 | 3 | 4.69% | 65 | 2 |
| Dec 31, 2022 | 64 | 29 | 82.86% | 63 | 1 |
| Dec 31, 2021 | 35 | 13 | 59.09% | 34 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Alps Group | 93 |
| XBiotech | 87 |
| MindWalk Holdings | 77 |
| Boundless Bio | 28 |
| Spero Therapeutics | 25 |
| INmune Bio | 21 |
| MiNK Therapeutics | 15 |
LONA News
- 1 day ago - LeonaBio Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 9 days ago - LeonaBio to Participate in Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 24 days ago - LeonaBio price target lowered to $15 from $16 at Mizuho - TheFly
- 26 days ago - LeonaBio price target lowered to $17 from $18 at Citizens - TheFly
- 4 weeks ago - LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - LeonaBio Quarterly report: Q2 2026 - Filings
- 4 weeks ago - LeonaBio Earnings release: Q2 2026 - Filings
- 4 weeks ago - LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer - GlobeNewsWire